Social Determinants of Health and their Impact on COVID-19

Immunological and Autoimmune Disorders

Thyroid awareness month

January month is the Thyroid awareness month, and it is a great way to comprehend the treatment, prevention, and causes of thyroid-related diseases and cancer for the people who are affected.One of...

Jan 28, 2020

Thyroid eye disease
Thyroid eye disease market: New therapies enter the TED market

The newly approved drug teprotumumab can offer hope to adults with thyroid eye disease, a rare and potentially blinding condition. It's the first treatment specifically approved for thyroid eye disease. The drug of Horizon Therapeutics was approved by the U.S. Food and Drug Administration and is set to be marketed ...

Find More
Pharma News
Tepezza receives approval; a new way to treat Alzheimer’s

Horizon Therapeutics has become the first company to receive the regulatory approval of its drug Tepezza for the cure of Thyroid Eye Tepezza (teprotumumab-trbw) is the first-ever treatment approved for thyroid eye is a progressive autoimmune disorder hampering the ability of vision. The drug was approved under P...

Find More
Pharma news
Imfinzi combo gets ODD; Mayzent gets EU nod; Positive results of VP-102

The US FDA has recently granted Orphan Drug Designation to AstraZeneca’s Imfinzi (durvalumab) and tremelimumab, combination therapy for HCC. Imfinzi, a monoclonal antibody, binds and inhibits the interaction of PD-L1 with PD-1 and CD80. The drug blocks tumour’s immune-evading mechanism and releases the inhibiti...

Find More

More Views & Analysis

Pharma News
Thumbs down to NKTR-181, Lilly expands its insulin armamentarium

The US FDA has voted down Nektar Therapeutics’ opioid painkiller NKTR-181, designed to treat lower back pain.  The FDA’s Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee unanimously has decided not to recommend the use of the painkiller, ta...

Find More

pharma news
Eli Lilly to acquire Dermira, Boehringer buys Enleofen’s IL-11 platform, Biogen acquires Pfizer’s Alzheimer’s drug

Eli Lilly has announced to buy a biopharmaceutical company, Dermira, for a whopping sum of USD 1.1 Billion in an all-cash transaction. Through the acquisition, Eli Lilly is planning to expand its immunology pipeline by adding lebrikizumab, which is a novel, investigational, monoclonal antibody. The drug is desi...

Find More

Egg Allergy Market
Egg Allergy Market: Second most common food allergy but no approved therapy

Hen’s egg allergy is the second most common type of allergy after cow’s milk. In infants and young children, Egg poses as one of the most vital allergens degrading the quality of life.  As per estimates, as many as 2 per cents of children are allergic to eggs. However, around 70% of these children are fortunate ...

Find More

Allergic rhinitis market
Allergic rhinitis market: How common is Hay fever?

Allergic diseases, such as allergic rhinitis (hay fever), food allergy, and eczema, are common allergies that affect people from all over the world. As per CDC, allergies are one of the top ten causes of chronic illness in the USA, afflicting around 50 Million Americans every year. The economic burden of Allergies ...

Find More

Allergic disease market
Global Allergic disease market

An allergy is a response produced by the body’s immune system to any foreign substance which is not usually harmful. These foreign substances can be anything ranging from food products such as peanuts, egg, lactose, or pollen grains, dust particles, or pet dander.  There are several forms of allergies such ...

Find More

Pharma News
Omega’s sixth funding round; Correvio’s drug failure; and BIMA acquisition

A leading global international investment firm, Omega Funds has announced the closure of its sixth fundraising USD 438 Million. More than decade old Life Sciences-based investment firm specialized in direct secondary transactions, Omega funds focuses in investing in Life Sciences vertical, aiming to fulfil the ...

Find More

A rare autosomal recessive disorder, Familial chylomicronemia syndrome (FCS), affects 1 in 1 to 2 mi.....

Find More

Crohn's disease (CD) is a type of inflammatory bowel disease (IBD). In this condition, the immune sy.....

Find More

An autosomal metabolic disorder – Pompe disease results in deterioration of organs and tissues as .....

Find More

Atrial fibrillation market is brimming with novel therapies in different stages of clinical developm.....

Find More

Diabetic macular edema (DME) is an eye disease in which there is fluid buildup in the macula. Even t.....

Find More

There are about 200 different types of cancer, making it one of the most diverse types of indication.....

Find More